Author:
Sathekge Mike,Lengana Thabo,Modiselle Moshe,Vorster Mariza,Zeevaart JanRijn,Maes Alex,Ebenhan Thomas,Van de Wiele Christophe
Publisher
Springer Science and Business Media LLC
Subject
Radiology, Nuclear Medicine and imaging,General Medicine,Radiology, Nuclear Medicine and imaging,General Medicine
Reference27 articles.
1. O’Keefe DS, Su SL, Bacich DJ, Horiguchi Y, Luo Y, Powell CT, et al. Mapping, genomic organization and promotor analysis of the human prostate-specific membrane antigen gene. Biochim Biophys Acta. 1998;1443(1-2):113–27.
2. Maurer T, Eiber M, Schwaiger M, Gschwend J. Current use of PSMA-PET in prostate cancer management. Nat Rev Urol. 2016;13(4):226–35.
3. Evangelista L, Briganti A, Fanti S, Joniau S, Reske S, Schiavina R, et al. New clinical indications for 18F/11C-choline, new tracers for positron emission tomography and a promising hybrid device for prostate cancer staging: a systematic review of the literature. Eur Urol. 2016;70(1):161–75.
4. Rahbar K, Weckesser M, Huss S, Semjonow A, Breyholz HJ, Schrader AJ, et al. Correlation of intraprostatic tumor extent with 68Ga-PSMA distribution in patients with prostate cancer. J Nucl Med. 2016;57(4):563–7.
5. Chang S, Reuter V, Heston W, Bander N, Grauer L, Gaudin P. Five different anti-prostate-specific membrane antigen (PSMA) antibodies conform PSMA expression in tumor-associated neovasculature. Cancer Res. 1999;59(13):3192–8.
Cited by
102 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献